India's Clinical Trials Surge Demands Public Awareness

India's growing prominence as a destination for clinical trials has highlighted the need for increased public awareness, according to GlobalData, a data and analytics company. Despite a rise in clinical trials initiated by both domestic and multinational pharmaceutical companies in India, the general public remains largely unaware of these trials. 

The report suggests that raising awareness could benefit pharma companies and contract research organizations by diversifying trials and attracting a larger pool of participants. The lack of clinical trial awareness campaigns by pharma companies in India has been identified as a concern, with the report encouraging the use of strategic approaches and partnerships with medical institutions and local governments to educate patients about the benefits of participating in trials. Increased awareness is expected to dispel misconceptions, facilitate access to new treatments, and have a positive impact on the health sector.